StockNews.com Begins Coverage on Vascular Biogenics (NASDAQ:VBLT)

Equities research analysts at StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research report issued on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Other research analysts also recently issued research reports about the company. HC Wainwright downgraded Vascular Biogenics from a “buy” rating to […]